357 related articles for article (PubMed ID: 23468253)
1. Focus on the role of the CXCL12/CXCR4 chemokine axis in head and neck squamous cell carcinoma.
Albert S; Riveiro ME; Halimi C; Hourseau M; Couvelard A; Serova M; Barry B; Raymond E; Faivre S
Head Neck; 2013 Dec; 35(12):1819-28. PubMed ID: 23468253
[TBL] [Abstract][Full Text] [Related]
2. CXCR4-mediated adhesion and MMP-9 secretion in head and neck squamous cell carcinoma.
Samara GJ; Lawrence DM; Chiarelli CJ; Valentino MD; Lyubsky S; Zucker S; Vaday GG
Cancer Lett; 2004 Oct; 214(2):231-41. PubMed ID: 15363550
[TBL] [Abstract][Full Text] [Related]
3. Expression of the CXCL12/CXCR4 chemokine axis predicts regional control in head and neck squamous cell carcinoma.
León X; Diez S; García J; Lop J; Sumarroca A; Quer M; Camacho M
Eur Arch Otorhinolaryngol; 2016 Dec; 273(12):4525-4533. PubMed ID: 27328961
[TBL] [Abstract][Full Text] [Related]
4. Intratumoural level of SDF-1 correlates with survival in head and neck squamous cell carcinoma.
Clatot F; Picquenot JM; Choussy O; Gouérant S; Moldovan C; Schultheis D; Cornic M; François A; Blot E; Laberge-Le-Couteulx S
Oral Oncol; 2011 Nov; 47(11):1062-8. PubMed ID: 21840752
[TBL] [Abstract][Full Text] [Related]
5. SDF-1-CXCR4 axis: cell trafficking in the cancer stem cell niche of head and neck squamous cell carcinoma.
Faber A; Goessler UR; Hoermann K; Schultz JD; Umbreit C; Stern-Straeter J
Oncol Rep; 2013 Jun; 29(6):2325-31. PubMed ID: 23563306
[TBL] [Abstract][Full Text] [Related]
6. CXC chemokine receptor-4 antagonist blocks both growth of primary tumor and metastasis of head and neck cancer in xenograft mouse models.
Yoon Y; Liang Z; Zhang X; Choe M; Zhu A; Cho HT; Shin DM; Goodman MM; Chen ZG; Shim H
Cancer Res; 2007 Aug; 67(15):7518-24. PubMed ID: 17671223
[TBL] [Abstract][Full Text] [Related]
7. CXCL12 and CXCR4, but not CXCR7, are primarily expressed by the stroma in head and neck squamous cell carcinoma.
Clatot F; Cornic M; Berghian A; Marchand V; Choussy O; El Ouakif F; François A; Ruminy P; Laberge-Le-Couteulx S; Picquenot JM; Jardin F
Pathology; 2015 Jan; 47(1):45-50. PubMed ID: 25474514
[TBL] [Abstract][Full Text] [Related]
8. CXCL12/CXCR4 promotes laryngeal and hypopharyngeal squamous cell carcinoma metastasis through MMP-13-dependent invasion via the ERK1/2/AP-1 pathway.
Tan CT; Chu CY; Lu YC; Chang CC; Lin BR; Wu HH; Liu HL; Cha ST; Prakash E; Ko JY; Kuo ML
Carcinogenesis; 2008 Aug; 29(8):1519-27. PubMed ID: 18487224
[TBL] [Abstract][Full Text] [Related]
9. Functional effects of SDF-1α on a CD44(+) CXCR4(+) squamous cell carcinoma cell line as a model for interactions in the cancer stem cell niche.
Faber A; Hoermann K; Stern-Straeter J; Schultz DJ; Goessler UR
Oncol Rep; 2013 Feb; 29(2):579-84. PubMed ID: 23232503
[TBL] [Abstract][Full Text] [Related]
10. The pivotal role of CXCL12 (SDF-1)/CXCR4 axis in bone metastasis.
Wang J; Loberg R; Taichman RS
Cancer Metastasis Rev; 2006 Dec; 25(4):573-87. PubMed ID: 17165132
[TBL] [Abstract][Full Text] [Related]
11. Expression of CXCR4 and its down-regulation by IFN-gamma in head and neck squamous cell carcinoma.
Katayama A; Ogino T; Bandoh N; Nonaka S; Harabuchi Y
Clin Cancer Res; 2005 Apr; 11(8):2937-46. PubMed ID: 15837745
[TBL] [Abstract][Full Text] [Related]
12. Involvement of autocrine CXCL12/CXCR4 system in the regulation of ovarian carcinoma cell invasion.
Miyanishi N; Suzuki Y; Simizu S; Kuwabara Y; Banno K; Umezawa K
Biochem Biophys Res Commun; 2010 Dec; 403(1):154-9. PubMed ID: 21059341
[TBL] [Abstract][Full Text] [Related]
13. Chemokine (C-X-C motif) ligand 12 is associated with gallbladder carcinoma progression and is a novel independent poor prognostic factor.
Lee HJ; Lee K; Lee DG; Bae KH; Kim JS; Liang ZL; Huang SM; Suk Oh Y; Kim HY; Jo DY; Min JK; Kim JM; Lee HJ
Clin Cancer Res; 2012 Jun; 18(12):3270-80. PubMed ID: 22553346
[TBL] [Abstract][Full Text] [Related]
14. Construction of a CXCL12-KDEL fusion gene to inhibit head and neck squamous cell carcinoma metastasis by intracellular sequestration of CXCR4.
Zhang W; Wang X; Yue K; Liu S; Liu X
Biomed Res Int; 2015; 2015():195828. PubMed ID: 25866764
[TBL] [Abstract][Full Text] [Related]
15. Effect of head and neck cancer supernatant and CpG-oligonucleotides on migration and IFN-alpha production of plasmacytoid dendritic cells.
Thiel A; Pries R; Jeske S; Trenkle T; Wollenberg B
Anticancer Res; 2009 Aug; 29(8):3019-25. PubMed ID: 19661310
[TBL] [Abstract][Full Text] [Related]
16. Phenotypic knockout of CXCR4 by a novel recombinant protein TAT/54R/KDEL inhibits tumors metastasis.
Ma WF; Du J; Fu LP; Fang R; Chen HY; Cai SH
Mol Cancer Res; 2009 Oct; 7(10):1613-21. PubMed ID: 19825996
[TBL] [Abstract][Full Text] [Related]
17. Prognostic value of the chemokine receptor CXCR4 and epithelial-to-mesenchymal transition in patients with squamous cell carcinoma of the mobile tongue.
Albert S; Hourseau M; Halimi C; Serova M; Descatoire V; Barry B; Couvelard A; Riveiro ME; Tijeras-Raballand A; de Gramont A; Raymond E; Faivre S
Oral Oncol; 2012 Dec; 48(12):1263-71. PubMed ID: 22776129
[TBL] [Abstract][Full Text] [Related]
18. SDF-1/CXCR4 expression is an independent negative prognostic biomarker in patients with head and neck cancer after primary radiochemotherapy.
De-Colle C; Menegakis A; Mönnich D; Welz S; Boeke S; Sipos B; Fend F; Mauz PS; Tinhofer I; Budach V; Abu Jawad J; Stuschke M; Balermpas P; Rödel C; Grosu AL; Abdollahi A; Debus J; Belka C; Ganswindt U; Pigorsch S; Combs SE; Lohaus F; Linge A; Krause M; Baumann M; Zips D;
Radiother Oncol; 2018 Jan; 126(1):125-131. PubMed ID: 29061496
[TBL] [Abstract][Full Text] [Related]
19. The CXCL12-CXCR4 axis promotes migration, invasiveness, and EMT in human papillary thyroid carcinoma B-CPAP cells via NF-κB signaling.
Lin Y; Ma Q; Li L; Wang H
Biochem Cell Biol; 2018 Oct; 96(5):619-626. PubMed ID: 29316404
[TBL] [Abstract][Full Text] [Related]
20. Expression of CXCL12 and its receptor CXCR4 in esophageal squamous cell carcinoma.
Sasaki K; Natsugoe S; Ishigami S; Matsumoto M; Okumura H; Setoyama T; Uchikado Y; Kita Y; Tamotsu K; Hanazono K; Owaki T; Aikou T
Oncol Rep; 2009 Jan; 21(1):65-71. PubMed ID: 19082444
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]